SE0001914L - Förbättring av Peyronies sjukdom - Google Patents

Förbättring av Peyronies sjukdom

Info

Publication number
SE0001914L
SE0001914L SE0001914A SE0001914A SE0001914L SE 0001914 L SE0001914 L SE 0001914L SE 0001914 A SE0001914 A SE 0001914A SE 0001914 A SE0001914 A SE 0001914A SE 0001914 L SE0001914 L SE 0001914L
Authority
SE
Sweden
Prior art keywords
disease
peyronie
collagenase
plaque
improving
Prior art date
Application number
SE0001914A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE0001914D0 (sv
Inventor
Thomas L Wegman
Original Assignee
Advance Biofactures Curacao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Curacao filed Critical Advance Biofactures Curacao
Publication of SE0001914D0 publication Critical patent/SE0001914D0/xx
Publication of SE0001914L publication Critical patent/SE0001914L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE0001914A 1999-06-03 2000-05-23 Förbättring av Peyronies sjukdom SE0001914L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/325,224 US6022539A (en) 1999-06-03 1999-06-03 Amelioration of peyronie's disease

Publications (2)

Publication Number Publication Date
SE0001914D0 SE0001914D0 (sv) 2000-05-23
SE0001914L true SE0001914L (sv) 2000-12-04

Family

ID=23266961

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001914A SE0001914L (sv) 1999-06-03 2000-05-23 Förbättring av Peyronies sjukdom

Country Status (9)

Country Link
US (1) US6022539A (no)
AU (1) AU3532900A (no)
CA (1) CA2308842C (no)
DE (1) DE10027521A1 (no)
DK (1) DK177177B1 (no)
FR (1) FR2794369B1 (no)
GB (1) GB2352173B (no)
NO (1) NO333945B1 (no)
SE (1) SE0001914L (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2197018B1 (es) * 2002-06-06 2005-10-01 Especialidades Farmaceuticas Centrum Sa Nuevo uso terapeutico de los extractos de polypodium.
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
CA2593038C (en) * 2005-01-21 2015-03-17 Advance Biofactures Corporation Methods for treating adhesive capsulitis
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
US20080233614A1 (en) * 2007-02-13 2008-09-25 Cranenburgh Rocky M Production of recombinant collagenases colg and colh in escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
US20100159564A1 (en) * 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
WO2010022016A1 (en) * 2008-08-19 2010-02-25 Auxilium International Holdings, Inc. Method of treating peyronie's disease
US20110229451A2 (en) * 2009-03-06 2011-09-22 Halozyme, Inc. Temperature sensitive mutants of matrix metalloproteases and uses thereof
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease
US9180172B2 (en) * 2010-12-15 2015-11-10 Ams Research Corporation Treatment of Peyronies disease
WO2012125948A1 (en) 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
CN103687607B (zh) 2011-07-20 2018-01-30 麦迪伍德有限公司 用于治疗结缔组织疾患的来自菠萝蛋白酶的蛋白水解提取物
EP4276180B1 (en) 2012-01-12 2026-04-22 Endo Biologics Limited Clostridium histolyticum enzyme
US20180028575A1 (en) 2012-01-30 2018-02-01 Michael Zahalsky Methods and compositions for treatment of penile defects
WO2013116327A1 (en) * 2012-01-30 2013-08-08 Zahalsky Michael P Methods and compositions for treatment of penile defects
US20150196625A9 (en) 2013-01-07 2015-07-16 Rudolph D. Paladini Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof
US9744138B2 (en) 2013-03-15 2017-08-29 Biospecifics Technologies Corp. Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
IL327169A (en) 2017-03-01 2026-05-01 Endo Ventures Ltd A method for assessing and treating cellulite
US11473074B2 (en) 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
CA3157517A1 (en) 2019-10-15 2021-04-22 The Johns Hopkins University Treatment of uterine fibroids using purified collagenase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
EP0456724B1 (en) * 1989-01-27 1995-05-03 Immunolytics, Inc. Composition and method for treating benign prostatic hypertrophy
US6086872A (en) * 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease

Also Published As

Publication number Publication date
DK200000792A (da) 2000-12-04
US6022539A (en) 2000-02-08
CA2308842A1 (en) 2000-12-03
NO20002686D0 (no) 2000-05-25
FR2794369B1 (fr) 2003-11-21
AU3532900A (en) 2000-12-07
SE0001914D0 (sv) 2000-05-23
GB2352173A (en) 2001-01-24
GB2352173B (en) 2004-11-10
CA2308842C (en) 2013-02-12
DE10027521A1 (de) 2000-12-07
IE20000402A1 (en) 2001-01-10
NO20002686L (no) 2000-12-04
GB0011969D0 (en) 2000-07-05
FR2794369A1 (fr) 2000-12-08
NO333945B1 (no) 2013-10-28
DK177177B1 (da) 2012-04-30

Similar Documents

Publication Publication Date Title
SE0001914D0 (sv) Förbättring av Peyronies sjukdom
ATE338554T1 (de) Pharmazeutische zusammensetzungen zur behandlung von erektiler dysfunktion
ATE234626T1 (de) Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin mit glucocerebrosidase enzyme zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten
IL206830A (en) Use of an integrin-containing antagonist of the alpha 1 subunit - of the integrin to prepare a drug for the treatment of osteoporosis
ATE348808T1 (de) Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten
TW200505901A (en) Muscarinic agonists
PT977564E (pt) Forscolina para promocao da massa corporal magra
ATE226821T1 (de) Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten
EP1233670A4 (en) NITROGEN MONOXIDE DONORS FOR INDUCING NEUROGENESIS
AU8502198A (en) Method for treating vascular proliferative diseases with p27 and fusions thereof
HUP9901418A2 (hu) Eljárás levobupivakain és analóg hatóanyagok racemizálására
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
CO5280202A1 (es) Metodos de tratamiento y metodos de rastreo de farmacos
AP9901720A0 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors.
ES2145517T3 (es) Nuevos derivados monofuncionalizados de edta, dtpa y ttha y su utilizacion en el diagnostico y en la terapia medicinales.
ATE214278T1 (de) Verfahren und medikament zum vermindern des jet- lags
NZ318272A (en) Glucocorticoid enhancement of gene expression
ATE300311T1 (de) Vorbereitung eines medikaments zur behandlung von refluxösophagitis
DE60024408D1 (de) Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen
DE69904712D1 (de) Verwendung von deltorphin zur behandlung von zytokin-vermittelter leberschädigung
UA31638A (uk) Спосіб лікування увеїтів
UA36633A (uk) Спосіб лікування параноїдної шизофренії з суїцидальною поведінкою
TR200102245T2 (tr) Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.
UA30393A (uk) Спосіб лікування коронарного атеросклерозу
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘

Legal Events

Date Code Title Description
NAV Patent application has lapsed